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Abstract
Retinal vessel calibre has been found to be an important biomarker of several
retinal diseases, including diabetic retinopathy (DR). Quantifying the retinal
vessel calibres is an important step for estimating the central retinal artery and
vein equivalents. In this study, an alternative method to the already estab-
lished branching coefficient(BC) is proposed for summarising the vessel calibres
in retinal junctions. This new method combines the mean diameter ratio with
an alternative to Murray’s cube law exponent, derived by the fractal dimen-
sion,experimentally, and the branch exponent of cerebral vessels, as has been
suggested in previous studies with blood flow modelling. For the above calcu-
lations, retinal images from healthy, diabetic and DR subjects were used. In
addition, the above method was compared with the BC and was also applied to
the evaluation of arteriovenous ratio as a biomarker of progression from diabetes
to DR in four consecutive years, i.e. three/two/one years before the onset of
DR and the first year of DR. Moreover, the retinal arteries and veins around the
optic nerve head were also evaluated. The new approach quantifies the vessels
more accurately. The decrease in terms of the mean absolute percentage error
was between 0.24% and 0.49%, extending at the same time the quantification
beyond healthy subjects.
Keywords: Gamma ratio ; diabetic retinopathy ; vessel calibres ; Junction
∗Corresponding author. Tel.:+44(0)1522886873
Email address: gleontidis@lincoln.ac.uk (Georgios Leontidis)
Preprint submitted to Elsevier January 03, 2016
exponent; arteriovenous ratio;
1. Introduction
1.1. Background
The human retina is an important and non-invasive window for monitoring
the blood vessels, being a part of the brain vascular system [1]. In numerous
studies in literature, alterations of the retinal vessels have been associated with
diseases like diabetic retinopathy(DR) [2], hypertension [3] and glaucoma [4].
In diabetes and DR especially, changes have been identified both in the blood
flow and the vessel wall structure, leading to geometric alterations, which can
be measured in fundus images [5, 6, 7, 8]. According to the World Health
Organization, the global prevalence of diabetes is estimated to be 9% among
adults aged 18+ years. DR, during the advanced stages, has already caused
serious damages and can lead to blindness. Early detection of these alterations,
before the onset of DR, could possibly assist the clinicians in deciding a better
series of treatment interventions.
DR occurs when hyperglycaemia-induced (elevated blood sugar levels) ox-
idative stress begins to damage the cells at the back of the eye [9]. DR may
progress through four stages [10, 11]:
1. Background retinopathy, where small balloon-like swellings appear in
the retina’s blood vessels called microaneurysms.
2. Moderate non-proliferative retinopathy, where swelling and distor-
tion of the vessels might occur, as well as possibly losing their ability to
transport blood.
3. Severe non-proliferative retinopathy, where even more blood vessels
get blocked, depriving the blood supply to various areas of the retina.
These areas can stimulate the production of growth factors that signal
the retina to start growing new blood vessels.
4. Proliferative retinopathy. At this stage, the proliferation of new blood
vessels occurs, which grow along the inner surface of the retina and the
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Figure 1: Fundus images of a same patient, before (left) and after DR (right). No lesions exist
in the image on the left. Macular oedema and extensive retinal haemorrages can be seen in
the image on the right.
vitreous gel. These vessels are fragile, which makes them more likely to
leak and start bleeding. It is also possible that the scar tissue will contract
and cause the retina to be detached from the underlying tissue.
In addition, in the last stages of retinopathy, we might have additional symp-
toms, like retinal oedema and hard exudates,cotton-wool spots, venous loops
and venous beading and neovascularisation, which denote more advanced and
dangerous developments for the vision stages [12, 13, 14]. An example of the
same retina before and after diabetic retinopathy can be seen in fig.1.
The retinal vascular geometry offers a unique opportunity to study a number
of different diseases. However, to do so, reliable and robust methods are needed
in order to extract all of the relevant information for running the statistical
analysis. Measuring accurately and summarising the vessel trunks in the most
efficient way, even though the improvement might be subtle, can contribute
towards defining the biomarkers of the progression for a disease. Additionally,
taking into account that during the proliferation of retinal diseases, as defined
by the anatomical structure of the retinal vessels, any alteration is very fine, and
any possible improvement, no matter how negligible it might be, is undoubtedly
important.
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The main purpose of this study is to provide an alternative method of quanti-
fying the retinal vessel calibres. Even the slightest improvement of this quantifi-
cation can have a direct effect on studies of retinal pathologies, especially if we
take into account that in different diseases, like diabetes and DR, the vascular
changes are quite subtle (even less than 5%), especially during the consecutive
years of the disease’s progression [2]. In addition, these changes are difficult to
quantify in digitised images, which thus may warrant and justify the innovation
of methods to quantify those small changes in vessel calibers. The proposed
method aims to improve and generalize the quantification for healthy, diabetic
and DR eyes.
1.2. Related work
The central retinal artery (CRA) and vein (CRV) are the two main vessels
of the retina. The CRV leaves the optic nerve head, draining the blood from the
capillaries directly into either the superior ophthalmic vein or to the cavernous
sinus. Meanwhile, the CRA branches off the ophthalmic artery, passing under
the optic nerve head within its dural sheath to the eyeball [15]. Initially Parr
et al. [16, 17] and then Hubbard et al. [18] completed some important work
in the quantification of the retinal vessel calibres, which was then extended
and improved by Knudtson et al. [19]. In their methods, the central retinal
vein and artery equivalents (CRVE and CRAE) were proposed. In both cases,
the calibre measurements around the optic nerve head were combined into one
index, giving us the CRVE and CRAE. All of the measurements are collected
around the optic nerve head, in an area of interest that lies within 0.5 to 1.0
optic disc diameters from the optic disc margin. To improve the estimation,
Knudtson et al. revised the formulas used in the previous studies, in order to be
independent of the units of measurement (e.g. pixels or microns) and without
constant terms. The derived formulas for arteries and veins can be seen in eqs.1
and 2 respectively, which are based on branching coefficient values of 1.28 for
arteries and 1.11 for veins. The ratio between the CRAE and CRVE is known
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as arteriovenous ratio (AVR).
Arterioles : Wˆ = 0.88 ∗
√
(W 21 +W
2
2 ) (1)
V eins : Wˆ = 0.95 ∗
√
(W 21 +W
2
2 ) (2)
where wˆ is the estimate of the parent trunk arteriole or venule and w1, w2 are
the two branches (children).
It is worth mentioning that the data used to derive these formulas included
only normotensive subjects. However, as has been shown in previous studies
[2, 20], applying these formulas to diabetic and DR subjects give us different
estimates of the BC. This could lead to errors in measurements, in the event
that they were about to be used in summarising the vessel calibres in diabetic
and/or DR patients.
Following a similar logic, Patton et al. attempted to improve the above
formulas for calculating the BC, recruiting healthy subjects to measure the
retinal vessels calibres [21]. Following that, they tested the performance on a
different group of people that they also recruited. Their main method included
the design of a least-squares linear regression model for the arteries only, since
the main independent variable, the asymmetry index, was found to only be
related to the arteries and not the veins. Their developed model can be seen in
eq.3.
BC arteries model = 0.78 + 0.63 ∗Asymmetry index (3)
1.3. Proposed method
The relationship between parent and daughter vessels at vascular junctions
has been expressed by using the junction exponent(x) [22]. It has been shown
that deviations from the optimal value, as predicted by Murray’s cubic law
(x=3), can be an indication of a vascular disease. Witt et al. [23] proposed an
alternative parameter, which they called the optimality ratio, that is simpler
to calculate and more robust in the presence of noise than Murray’s junction
exponent [22].
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In addition, in another study [24], they assessed the arteriovenous distri-
bution of haemodynamic parameters throughout a microvascular network in-
side the human retina. They suggested an alternative value for the exponent,
based on the fractal dimension and a branch exponent, with the latter derived
from data on cerebral vessels, mainly because they share similar structural and
functional characteristics as the retina [25]. The reasoning behind this is that
Murray’s theoretical value of 3, actually ranges between 2.7 and 3.0 in various
vascular beds [26, 27]. Fractal dimension has been vastly studied in literature
and is primarily used to quantify complex vascular networks like the retina [28].
The branch exponent, which is also consistent with a fractal recursive rule, can
also define the relation between the length and radius of a branch segment as
L(r) =β ra. In the study of Takahashi et al. they used a value of 1.7 for fractal
dimension and 1.15 for the branch exponent [24].
In our proposed method, we combine the mean diameter ratio with a re-
vised exponent, which has been derived from data of healthy, diabetic and DR
subjects. Therefore, the final exponent, although it uses the standard branch
exponent of 1.15, as suggested in [24], it is combined with the fractal dimen-
sion, as we calculated for these three groups. The newly derived formulas were
compared against the BC of Knudtson et al. and the linear regression model of
Patton et al. for all the above cases, using the mean absolute percentage error
(MAPE).
The following study is organised into four main sections. In Section 1, a
thorough description of the methods and techniques is given, alongside the tools
and the data that were used. In Section 2, more details will be given for the
study of the evaluation of the AVR and the arteries and veins individually, as
biomarkers of progression to DR. Section 3 will be devoted to presenting the
results in two parts. The first part will present the comparisons between the
three techniques for summarising the retinal vessel calibres. The second part
will present the results and the statistical analysis for the study of progression
to DR, in the four different groups, using a repeated measures nested design. In
the last section, the implications and importance of this study will be addressed,
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followed by the conclusion.
2. Methods and Tools
2.1. Data Collection
All of the studies were performed according to the tenets of the Decla-
ration of Helsinki. As mentioned previously, numerous studies have shown
that the retinal vasculature changes during the progression of diabetes and
DR [8, 29, 30, 31, 32].Therefore, in order to improve the accuracy of the es-
timation of the trunk for both arteries and veins, different data for healthy,
diabetics with no-DR and DR subjects were used. All of the individuals in the
diabetic and DR groups had no history of hypertension or any other cardiovas-
cular disease. Twenty five images (each of 3888 x 2592 pixels) were chosen from
image database of healthy group in a previous, unpublished study, conducted at
the School of Computer Science at the University of Lincoln, UK.The diabetic
group included data from twenty five diabetic subjects taken annually, over a
three-year period, before the onset of DR (3 years pre-DR, 2 years pre-DR and
1 year pre-DR). The same exact junctions were used in all three cases, which
were then averaged and used to derive the formulas, constituting one group (age
range 35-60 years, mean 47.5 (±7.48) ). The rationale behind this is that in
order for the formulas to be useful in estimating the trunk in diabetic subjects,
which can be at different stages of diabetes, more than one year is needed to
have a more accurate representation of the junctions. Regarding the DR group,
twenty five DR patients in the early stages of DR were included (first and/or
second year that the first lesions appeared). The data of both these groups
comes from a diabetic/DR screening database in the UK (each of 3216 x 2316
pixels) (age range 37-70, mean 53.2 (±9.63)). The image resolution in the above
groups does not affect the implementation of the method since it is resolution-
invariant. Moreover, in all of the above cases, either the left or the right eye
was used, chosen at random before the beginning of the study.
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2.2. Tools
The junctions were labelled and measured using a semi-automated tool de-
scribed in [33]. Using this tool, each junction is firstly labelled manually as
being a vein or an artery and then in a second stage the calibre is determined
by fitting a rectangle between the wall edges of each vessel. The entire process
is conducted in a semi-automated manner, going through each junction. The
rectangle is adjusted by the user until he is confident that the measurement is
correct. In that way, if a junction cannot be accurately measured, then the user
can discard and select another one, making sure that the included measure-
ments are accurate. The process was repeated twice for every junction, taking
the average of the two measurements, after calculating the intrarater reliability
(95.6% (95%CI=94.3, 96.8) of agreement). The performance of the expert user
of the tool has been validated against a fully automated tool as proposed in
[34], with the average agreement being 96.1% (95%CI=95.1, 97.9).
The fractal dimension estimation was calculated using the well-established
box-counting algorithm, based on eq.4 [35]. The estimation starts with an evenly
spaced grid, followed by counting how many boxes are required to cover the set.
The final dimension is calculated by observing how this number changes as the
grid becomes finer, by applying the box-counting algorithm. Initially, the fundus
images are segmented using a tram-line algorithm as proposed in [36] (fig.2). In
the second stage, the box-counting method is applied in the binary segmented
trees, getting the fractal dimension in [36]. All of the analyses and algorithms
were implemented using Matworks Matlab 2015b software and the open source
Rstudio [37].
FD = lim
r→0
LogN(r)
Log(1/r)
, (4)
where N(r) is the number of boxes of side length r that have to be used to
cover a given area in the Euclidean n-space, by using a sequential number of
descending size boxes. This occurs in multiple orientations. The final dimension
in the 2D space is between 1 and 2.
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2.3. Gamma Ratio
It is well known that the relationship between the parent and daughter ves-
sels’ diameters at a branch is described by the junction exponent(x) defined by
eq.5.
dx0 = d
x
1 + d
x
2 , (5)
where d0 is the diameter of the parent vessel and d1, d2 are the daughter vessels’
diameters [22]. Murray’s law predicts that this exponent is equal to 3 under
conditions of optimum power loss in the bifurcation. A few studies have shown
that healthy veins and arteries follow Murray’s law with the exception of very
large vessels [26, 38].
Witt et al. suggested an alternative parameter to characterise the optimality
of the relationship between the vessels’ diameter at a bifurcation, which they
called the optimality ratio, aiming to reduce the bias and variability in the
presence of noise in the measurements of individual vascular diameters, from
which the junction exponent calculation suffers. This optimality ratio is based
on the non-dimensional variants ζ1, ζ2 of the daughter diameters at birfurcation
(eq.6).
ζ1 =
d1
d0
, ζ2 =
d2
d0
(6)
After a few transformations, the mean diameter ratio Γ is calculated by the
eq.7.
Γ =
d1 + d2
2d0
=
ζ1 + ζ2
2
(7)
Finally, after some algebraic manipulations of the mean diameter ratio and the
asymmetry factor, they define the optimality ratio for a bifurcation obeying
Murray’s cubic law as
Γratio =
(
d31 + d
3
2
2d30
) 1
3
(8)
More information for the above derivation of the formula is given in [23].
2.4. Exponent
As mentioned previously, Murray’s cubic law of x=3 has actually been found
to range between 2.7 and 3.0 for various vessels. Following the mathematical
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Figure 2: Two segmented images used for this study. The vessels inside the optic nerve head
are excluded from the fractal dimension calculation.
proofs of Takahashi et al. [24], showing that this exponent can be approximated
more accurately by combining the fractal dimension and a branch exponent,
this was derived experimentally from patients’ data for healthy, diabetic and
DR eyes.
2.5. Fractal Dimension
All of the 125 images (25 for healthy, 75 for diabetic and 25 for DR eyes)
were segmented and the binary trees were used to calculate the fractal dimen-
sion (fig.2). In the diabetic group, the fractal dimensions of the same retinas
were averaged over the three year period, in order to get a more accurate repre-
sentation of the multiple and versatile changes that occur during the progression
of diabetes. The final 25 measurements for each of the three groups (healthy,
diabetic and DR) were summarised using both the mean and median values.
Therefore, all of the experiments were run using both the mean and median
fractal dimension to derive the exponent.
2.6. Adjusted Γratio
The general form of the adjusted Γ ratio, using the experimentally measured
fractal dimension, combined with the branch exponent of 1.15 is summarised in
eq.9,
Adj.Γratio =
(dm1 + dm2
2dm0
) 1
m , (9)
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where m is taking 6 different values, for the three groups and for the mean and
median fractal dimensions. By solving eq.9 with respect to the parent vessel d0,
we get the generalised eq.10, which, after adjusting for the different exponents,
will be used in all of the following experiments and will be compared against
the other two methods in the literature [19, 21].
trunkvessel d0 =
m
√
dm1 + d
m
2
2 ∗ 1m√adjΓratio
= m
√
dm1 + d
m
2
2 ∗ (adjΓratio)m (10)
2.6.1. Group Itemised Γratio
In Table 1, the experimental results of the three groups can be found.Depending
on the value of the exponent, the adjusted Γratio has been calculated based on
eq.9. For each exponent, we derived the corresponding equation, in order to cal-
culate the performance within the different groups, for both veins and arteries,
using the mean and median FD. In total, we obtained 12 equations to be used
and compared against the other two methods.
V ein : Healthy d0 mean =
2.8
√
d2.81 + d
2.8
2
0.8894
(11)
V ein : Healthy d0 median =
2.78
√
d2.781 + d
2.78
2
0.8936
(12)
V ein : Diabetic d0 mean =
2.76
√
d2.761 + d
2.76
2
0.9377
(13)
V ein : Diabetic d0 median =
2.79
√
d2.791 + d
2.79
2
0.9317
(14)
V ein : DR d0 mean =
2.74
√
d2.741 + d
2.74
2
0.9314
(15)
V ein : DR d0 median =
2.77
√
d2.771 + d
2.77
2
0.9253
(16)
Arteries : Healthy d0 mean =
2.8
√
d2.81 + d
2.8
2
1.079
(17)
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Arteries : Healthy d0 median =
2.78
√
d2.781 + d
2.78
2
1.0826
(18)
Arteries : Diabetic d0 mean =
2.76
√
d2.761 + d
2.76
2
1.118
(19)
Arteries : Diabetic d0 median =
2.79
√
d2.791 + d
2.79
2
1.1129
(20)
Arteries : DR d0 mean =
2.74
√
d2.741 + d
2.74
2
1.152
(21)
Arteries : DR d0 median =
2.77
√
d2.771 + d
2.77
2
1.1465
(22)
Table 1: Group specific measurements
Group Number of
Junctions
(Images)
Mean/Median
FD(SD)
Adjusted
Γmedian
(CI 95%)
Adjusted
Γmean
(CI 95%)
Exponent
m
(mean/median)
Healthy
Veins
150(25) 1.646/1.633
(0.03)
0.7484
(0.736,0.7564)
0.7487
(0.7363,0.7568)
2.8/2.78
Diabetic
Veins
450(75) 1.613/1.638
(0.035)
0.7605
(0.7514,0.77)
0.76
(0.751,0.7696)
2.76/2.79
DR
Veins
150(25) 1.591/1.621
(0.028)
0.7571
(0.7519,0.7714)
0.7566
(0.7418,0.771)
2.74/2.77
Healthy
Arteries
150(25) 1.646/1.633
(0.03)
0.8019
(0.7886,0.8084)
0.8022
(0.7888,0.8086)
2.8/2.78
Diabetic
Arteries
450(25) 1.613/1.638
(0.035)
0.8105
(0.789,0.8185)
0.81
(0.787,0.862)
2.76/2.79
DR
Arteries
150(25) 1.591/1.621
(0.028)
0.818
(0.801,0.837)
0.8176
(0.799,0.833)
2.74/2.77
12
2.7. Methodology of Arteriovenous Ratio
Knudtson et al. suggested using a region around the optic nerve head in
order to estimate the CRVE and CRAE and also calculate their quotient, the
arteriovenous ratio (AVR). They also observed that the number of vessels used
does not affect the final estimation. We adopted this methodology here to make
the AVR estimation. Therefore the area used can be seen in fig.3.
However, although the number of vessels might not significantly affect the
final estimation, the branching order plays an important role. In an example
that will be presented later on, the final estimation is affected when vessels of
different branching order are combined. Nevertheless, just looking at the fundus
images, someone cannot be certain about the branching order of the vessel that
is measuring, since the vessels might have branched before they exit the bright
optic nerve head area. Having said this, in many retinas, the excluded area,
which is 0.0-0.5 optic disc diameters from the optic nerve head margin, hides
the branching of some segments. Therefore zone B (fig.3) might include vessels
of different branching order. The same problem however exists to the area inside
the optic nerve head, where the branchings cannot be identified as well.
Taking into consideration the reasons above and despite the drawbacks of
this methodology, and also since the branching order cannot be accurately de-
fined, we have adopted the established zone B, where the vessels are larger and
more accurately measured and their status is already attained.
Another issue is that in [19], the six vessels are summarised using an itera-
tive process, where the largest vessel is paired with the smallest one and then
the second largest with the second smallest and so on. However, experimentally
testing that by summarising four different trunk vessels using six subsequent
vessels (daughters) of the same tree showed that both this method and simply
taking the vessels in an ascending order, lead to mixed results (two versus two),
when compared against the actual measured trunks (Table 3). Therefore, ac-
cording to these four trunks estimations, there is no evidence that one method
is consistently more accurate than the other.
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Figure 3: Schematic representation of the region used for calculating the CRVE, CRAE and
AVR [19].
2.8. Comparison of Methods
In contrast to the method in [19], the method in [21] includes only the
arteries, hence the comparison with this one will only be limited to the arteries.
For the other method a full comparison will be made. In addition, despite the
fact that in previous studies [2, 20], updated branching coefficients for both
diabetic and DR groups have been reported, the purpose of this study is not
to revise the established methods rather to propose a new one. Therefore these
methods are utilised exactly as they have been described in literature and used
by other researchers.
2.8.1. Statistical Analysis
In order to compare the performance and accuracy of the estimations of the
proposed method against the other two, we use the mean absolute percentage
error (MAPE), which is defined as:
MAPE =
1
n
n∑
i=1
∣∣∣∣Ai − PiAi
∣∣∣∣ ∗ 100%, (23)
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where Ai is the actual measurement and Pi is the predicted one.
The whole sample of junctions is initially partitioned in 10 equal parts, in
order to run a 10-fold cross-validation. For instance, for the healthy group, each
time the formulas are derived using 135 junctions and tested with the other 15;
this process is repeated for all the combinations. This means that all of the
above equations, as well as the reported errors, are the overall average of the
iterations. In the above way we avoid the bias that arises from using the same
data for training and test purposes.
In addition, in order to justify taking multiple junction measurements from
the same image, we compared the within each image variation with the between
images variation, using the intraclass correlation coefficient (ICC).
Finally, for the progression study, using the individually measured vessels,
a mixed model design was used, analysed by a repeated measures analysis of
variance (ANOVA), as described in [2], which accounts for the multiple mea-
surements taken within the same fundus images. For the AVR, a simple re-
peated measures ANOVA was used. Normality, using the Shapiro-Wilk test,
and sphericity, using the Mauchlys test, were run prior to the analysis, to make
sure that the data can be analysed using this type of test. Effect sizes according
to the partial η2 were also reported for the CRVE, CRAE and AVR. Post-hoc
comparisons, adjusted according to the Bonferroni correction were also made
for the significant results (CRVE, CRAE and AVR), in order to specify which
group means actually differ. All of the analyses were fulfilled using a balanced
design.
2.8.2. Summary of Vessel Branch
In fig.4 we can see two example images out of the four that were used, to
estimate the trunk veins. In each of these cases, the trunk vein is estimated from
the subsequent daughter veins of different orders. The number 1 is the trunk
vein, and 2, 3, 4, 5, 6, 7 are the six veins that are used to estimate the trunk.
The same four images were used to compare the ascending order iteration and
the largest-smallest.
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Figure 4: Two example images that were used for quantifying the vein trunk and also compare
the two methods against each other, using both the established methodology and an ascending
iteration process. On the left the branching order is equal, whereas on the right it is uneven.
Such case is common when estimating the CRVE/CRAE, where some daughter segments
might belong to a lower order.
2.9. Biomarkers of Progression to DR
To study the progression from diabetes to DR, many different biomarkers
have been evaluated in literature, including widths, tortuosity, fractal dimen-
sion, branching angles etc. However the purpose of this study is primarily to
assess the proposed method of quantifying the vessel calibers and subsequently
apply them in a diabetic/DR progression study, in order to figure out whether
the results of the analysis change according to the utilised method. Supplemen-
tary to this, since the six veins and six arteries are measured to estimate the
CRVE/CRAE and their quotient, the same ones are used for comparison over
the four consecutive years of progression (last three years of diabetic eye and
the first year of DR). A schematic representation of this can be seen in fig.5. In
both these studies, 200 fundus images from 50 diabetic patients who progressed
to DR were used, extracting and measuring 2,400 vessels in total (1,200 veins
and 1,200 arteries).
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Figure 5: Schematic representation of how the individual arteries and veins are structured in
order to be statistically analysed.
3. Results
Firstly, the intraclass correlation coefficient was 0.12 (95%CI=0.11-0.15) for
the arteries and 0.14 for the veins (95%CI=0.12-0.17). In this way, we are
confident that each fundus image has no more variation than the variation that
we have between the images. Additionally, each method is correlated with the
other, with the correlation coefficients ranging from 0.975 to 0.989.
3.1. Proposed method
In Table 2 we can see the estimate errors for all the methods. The proposed
method marginally improves the quantification of the vessel calibres for every
group under consideration. In addition, in Table 3 we can see the results of
the quantification of four different vein trunks from four different retinal eyes.
In absence of data of the actual measurements of the central retinal arteries
and veins, this is the closest alternative to simulating a real case scenario and
presenting the performance of the methods as well.
The first two cases refer to the trunk veins of two healthy eyes, whereas the
third and fourth refer to the trunk veins of two diabetic eyes. The results of the
estimation of the trunk veins for these cases can be seen in table 3.
1. 10.30, 6.7, 5.9, 7.9, 9.4, 8.9
2. 10.60, 6.9, 6.4, 7.6, 8.9, 8.2
17
Table 2: Comparison between methods for the vessel calibre quantification (MAPE)
Group Proposed method
(Mean/Median)(CI95%)
Knudtson et al.
(CI95%)
Pratton et al.
(CI95%)
Healthy
arteries
7.83%(0.0705,0.086)/
7.81%(0.0707,0.0858)
8.05%
(0.0727,0.883)
8.01%
(0.0730,0.0881)
Diabetic
Arteries
9.21%(0.0819,0.1023)/
9.21%(0.0825,0.1012)
9.45%
(0.084,0.1087)
9.41%
(0.087,0.1101)
DR
arteries
7.1%(0.0575,0.0845)
7.09%(0.0583,0.0853)
7.58%
(0.0623,0.0887)
7.56%
(0.0634,0.0895)
Healthy
veins
6.8%(0.0611,0.0774)/
6.83%(0.0615,0.0777)
7.22%
(0.0642,0.0803)
-
Diabetic
veins
6.79%(0.0609,0.0750)/
6.81%(0.0611,0.0752)
7.11%
(0.0637,0.0780)
-
DR
veins
6.74%(0.0577,0.0741)/
6.75%(0.0579,0.0744)
7.15%
(0.06,0.0794)
-
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Table 3: Quantification of vein trunks
Veins Proposed
method
Knudtson et al. Ascending grouping
(Knudtson/Leontidis)
Measured
value
case1 17.88 17.8 17.91/17.74 19.54
case2 17.66 17.55 17.69/17.49 19.2
case3 20.03 20.60 20.79/19.91 19.65
case4 20.02 20.46 20.64/19.91 18.33
3. 13.1, 9.1, 8.5, 10.2, 9.7, 5.8
4. 6.3, 10.8, 10.7, 13.1, 9, 5
As it was anticipated, the results are quite close, however a difference does
indeed exist. The more accurate the estimation of the vessel trunk is, the more
constructive the statistical analysis will be as well. And despite the close mean
absolute percentage errors between the methods, when used in a real example
(Table 3), the differences are more extensive and can make an actual difference,
especially when studying the progression of a disease.
3.2. Classification
In order to illustrate the proposed improvement in an additional manner,
we utilised a logistic regression classifier. The purpose of this work is not to
build a classification system, rather to show an example of how this method
of quantifying the retinal vessels could improve the performance of a system in
conjunction with other features. To do so, we trained an elastic-net regularised
logistic regression classifier in Rstudio, using the package glmnet, according to
the method proposed in [39]. This algorithm linearly combines the L1 (least
absolute shrinkage and selection operator) and L2 (ridge regression) penalties,
using a cyclical coordinate descent, computed along a regularisation path, in
order to improve prediction accuracy. The difference with the ordinary logistic
regression has to do with the penalty parameter, which is applied to the co-
efficients. In LASSO [40], the penalty corresponds to a Laplace prior, which
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expects some coefficients to be zero or close to zero, in addition to a subset
of non-zero coefficients. In the case of ridge regression [41], the coefficients of
correlated parameters are shrunk towards each other, reducing the variance of
the estimates. More information of the elastic-net can be found in the extensive
work of Friedman et al. [39].
AVR, CRVE and CRAE were the three features used inside the binary clas-
sification system. Given the limited amount of data and the use of only three
features, this system was trained and applied between two groups: the diabetic
and the DR group. The Receiving Operating Characteristic (ROC) curve of the
two methods under comparison, the proposed and the Knudtson et al. method,
can be seen in fig.6, which was produced after running a 10-fold cross validation
process. After evaluating them inside the elastic-net logistic regression, all three
features were found to contribute to the performance of the classifier.
The average Area under the ROC curve was 0.594 for the proposed method
and 0.581 for the method of Knudtson et al. As initially indicated by the
decrease of the MAPE of the proposed method, the above classification also
indicates that getting more accurate quantification can in turn lead to a better
performance of a multi-feature classification system.
3.3. Analysis of AVR
Firstly, no violation of normality and sphericity was observed in either of
the investigated cases(p-values ranging from 0.27 to 0.46 and from 0.18-0.26
respectively). In Table 4 we can see the results of the analysis for the AVR
data, as well as for the CRVE and CRAE separately, using both the proposed
method and the method in [19], since the method in [21] refers only to the
arteries.
In this experiment, the semi-automated tool described in [33] was used to
manually label the arteries and veins. The methodology of Knudtson et al.
was followed, using the six largest veins and six largest arteries to estimate the
CRVE and CRAE.
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Figure 6: ROC curves showing the performance of the two methods. The blue line shows the
proposed method, whereas the red line represents the method of Knudtson et al. [19]
.
In fig.7 we can see the within subjects confidence intervals for both meth-
ods. Adjusting the p-values according to the Bonferroni correction, pairwise
comparisons using the method in[19] gave significant results for both the CRVE
and CRAE for the groups 3ypreDR/DR, 2ypreDR/DR and 1ypreDR/DR, but
not for any other combination (p-values ranged from 0.0001-0.007 for CRVE
and 0.0006-0.008 for CRAE). No significant result was observed for the AVR
whatsoever. Similarly, using the proposed method, significant results were found
from the same combinations as above, apart from the group 2ypreDR/DR of the
CRAE(p-values ranged from 0.0009-0.005 and 0.003-0.008 for CRVE and CRAE
respectively). Likewise, no significant results were observed for any combination
of the AVR.
3.4. Analysis of Vessels’ calibres
Similarly, no violation of either normality or sphericity was observed for the
individual abalysis of vessels’ calibers (p-values=0.28, 0.35 for veins and arter-
ies for normality and p-values=0.32, 0.37 for veins and arteries for sphericity).
Table 4 presents the analysis of the progression study in details. As we can see,
the differences are significant for both veins and arteries, which is in agreement
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Figure 7: On the left: Error bars for the within subjects confidence intervals of the AVR,
using the proposed method; on the right a similar plot using the method in [19].
Table 4: Results of the progression study
Scenario p-value
(a=0.05)
F-value
(dfn,dfe)
Effect size
partial-η2
Group means (SD)
(3y, 2y, 1y, DR)
CRVE(Knud.) 0.002 5.49
(3,147)
0.12 29.56(4.93),27.50(4.45),
28.19(5.03),27.14(4.89)
CRAE(Knud.) 0.009 4.11
(3,147)
0.10 20.1(2.99),19.33(2.86),
19.56(3.07),19.87(2.82)
AVR(Knud.) 0.10 2.04
(3,147)
0.06 0.688(0.0819),0.704(0.082),
0.702(0.094),0.723(0.093)
CRVE(Leon.) 0.003 5.16
(3,147)
0.13 28,88(4.77),26.88(4.40),
27.28(5.03),27.04(4.73)
CRAE(Leon.) 0.02 3.02
(3,147)
0.09 20.12(3.04),19.37(2.93),
19.52(3.03),19.28(2.75)
AVR(Leon.) 0.31 1.33
(3,147)
0.08 0.691(0.081),0.712(0.084),
0.718(0.091),0.0723(0.092)
Veins 0.0000 9.1
(3,897)
- 13.32(4.36),12.38(4.03)
12.72(4.2),12.51(4.21)
Arteries 0.0005 6.01
(3,897)
- 11.25(2.99),10.89(2.83)
10.95(2.9),11.01(2.96)
22
with studies in the literature that investigated the vessel calibres in the whole
retina. It is worth pointing out that due to the diverse nature and uniqueness
of each person’s retina, studying the progression in a repeated measures way,
at the exact same segments over a period of a few years, yields more accurate
results, increasing the power of the study at the same time [42].
Finally, significant results were also observed for all of the combinations
of artery and vein calibres, apart from the group 3ypreDR/2ypreDR, when
analysed in a two-group design (p-values ranged from 0.0003-0.002 and 0.0009-
0.006 for veins and arteries accordingly).
4. Discussion
As has been shown in previous studies [43, 44, 2], both geometric and haemo-
dynamic features can be studied for different diseases inside the human retina.
However, due to factors such as the different modalities used, the low image
quality of real-world data and the difficulty of implementing tools that will ac-
count for all these properties consistently and accurately, the study of diseases
is a difficult process, leading to ambiguous and contradicting results. Therefore,
our present study focused on trying to bridge this gap and introduce some new
and more general formulas for the vessel quantification for healthy, diabetic and
DR subjects.
A crucial point when calculating the CRVE and CRAE around the optic
nerve head, is that the exact branching order remains uncertain, and it is also
unclear whether the vessels have branched before they come out of the optic
nerve head or not. As we showed in fig.4, we simulated this scenario by quanti-
fying the vessel trunk in uneven branching order daughter vessels. Even in this
case, the quantification proved to be more accurate (case 3 in Table 3), which
covers this important possible situation. The more accurate the quantification
is, the more robust and meaningful the statistical inferences will be as well. In
this work, we offered an alternative-a more generalised and improved method
for quantifying the retinal vessel calibres, adding up to the previous works found
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in [17, 18, 19, 21]. As a logical future step, we will investigate further scenarios
and include an even larger sample, in order to possibly identify other areas that
could be improved as well.
5. Conclusion
A new approach for summarising the retinal vessel trunk has been proposed.
The improvement in terms of the mean absolute percentage error, ranged from
0.24% to 0.49%, whereas the improvement in the classification capability of the
proposed method against the Knudtson et al. between the diabetic and the DR
group was 0.013 of the AUC. Using the new derived formulas one can estimate
and summarise more accurately the retinal vessel trunks and use them in studies
of retinal diseases. In addition, if we take into account that during the iteration
process, six vessel calibres are summarised before the final vessel trunk value is
estimated, then the actual improvement is more extensive than what the mean
absolute percentage error suggests, since the errors are accumulated during the
process (Table 3).
The progression study that was also presented shows a difference between
the methods, both in the results of the estimation of the CRVE,CRAE and
AVR and in the statistical analyses. Therefore it is apparent that the improved
estimations lead to even more accurate analysis of the data.
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